Delivery Order SPE2DB20D3304-SPE2DB25FW8L4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 8, 2025, with a completion date of August 29, 2025, is structured as a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,846.32 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on August 11, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $65,022.93 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract awarded on August 27, 2025, with a completion date of September 18, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,105.92 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion date of June 17, 2025. This firm fixed-price delivery order represents a non-competitive procurement issued under the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents totaling $6,192.66 under a firm fixed price contract type. This award, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $2,085.12, with completion targeted for October 2, 2025. This is a non-set-aside competitive award, with performance conducted at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger DLA Troop Support Medical indefinite delivery contract (SPE2DX),...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8L4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The place of performance is located in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support global military healthcare programs. The Varivax vaccine delivery supports the Defense Health Agency and other federal healthcare systems' immunization requirements, consistent with AmerisourceBergen's established role as a prime pharmaceutical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/11/25 |